Jean-Jacques Degroof is an entrepreneurship mentor and teacher who has played key roles in the development of numerous ventures in Europe and the United States. Holding a PhD from the Massachusetts Institute of Technology, Jean-Jacques Degroof continues to maintain a relationship with the institute through the Aging Brain Initiative. Scientists at MIT recently announced the development of a drug that they believe could be effective in the treatment of COVID-19. The drug uses a protein fragment that mimics a protein found on human cells. The mechanism of action is quite unique. The drug binds to the protein that coronaviruses rely on to enter human cells and disarms it. In this way, the new drug could inhibit the virus’s ability to enter cells and create an infection. Initial findings about the drug were revealed on March 20, and several samples have been sent to initiate collaborative research on its potential. Research on campus was minimized recently to reduce person to person interaction, but the lab researching this new drug was granted special permission to continue its efforts.
0 Comments
Leave a Reply. |
|